Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol

被引：0
|
作者：
Joshua A. Lile
Thomas H. Kelly
David J. Pinsky
Lon R. Hays
机构：
[1] University of Kentucky College of Medicine,Department of Behavioral Science
[2] University of Kentucky College of Arts and Sciences,Department of Psychology
[3] University of Kentucky College of Medicine,Department of Psychiatry
[4] University of Kentucky College of Medicine,Department of Internal Medicine
[5] University of Wilmington,Department of Psychology
[6] College of Medicine,Department of Behavioral Science
[7] University of Kentucky,undefined
来源：
Psychopharmacology | 2009年 / 203卷
关键词：
Drug-discrimination; Subjective effects; Δ; -THC; Triazolam; Hydromorphone; Methylphenidate; Marijuana;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 250
页数：9
相关论文
共 50 条
  • [1] Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
    Lile, Joshua A.
    Kelly, Thomas H.
    Pinsky, David J.
    Hays, Lon R.
    [J]. PSYCHOPHARMACOLOGY, 2009, 203 (02) : 241 - 250
  • [2] Separate and combined effects of gabapentin and 9-tetrahydrocannabinol in humans discriminating 9-tetrahydrocannabinol
    Lile, Joshua A.
    Wesley, Michael J.
    Kelly, Thomas H.
    Hays, Lon R.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2016, 27 (2-3): : 215 - 224
  • [3] Substitution Profile of the Cannabinoid Agonist Nabilone in Human Subjects Discriminating Δ9-Tetrahydrocannabinol
    Lile, Joshua A.
    Kelly, Thomas H.
    Hays, Lon R.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2010, 33 (05) : 235 - 242
  • [4] The reinforcing, self-reported performance and physiological effects of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users
    Lile, Joshua A.
    Kelly, Thomas H.
    Hays, Lon R.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2010, 21 (01): : 29 - 38
  • [5] Sublingual administration of Δ9-tetrahydrocannabinol/β-cyclodextrin complex increases the bioavailability of Δ9-tetrahydrocannabinol in rabbits
    Mannila, J
    Järvinen, T
    Järvinen, K
    Tervonen, J
    Jarho, P
    [J]. LIFE SCIENCES, 2006, 78 (17) : 1911 - 1914
  • [6] Determination of Δ9-tetrahydrocannabinol in food
    Georgi, K
    Mavric, E
    Speer, K
    [J]. DEUTSCHE LEBENSMITTEL-RUNDSCHAU, 2002, 98 (10) : 363 - 366
  • [7] Excretion of Δ9-tetrahydrocannabinol in sweat
    Huestis, Marilyn A.
    Scheidweiler, Karl B.
    Saito, Takeshi
    Fortner, Neil
    Abraham, Tsadik
    Gustafson, Richard A.
    Smith, Michael L.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2008, 174 (2-3) : 173 - 177
  • [8] Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol
    Chan, GCK
    Hinds, TR
    Impey, S
    Storm, DR
    [J]. JOURNAL OF NEUROSCIENCE, 1998, 18 (14): : 5322 - 5332
  • [9] Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
    Goodivin, Robert S.
    Gustafson, Richard A.
    Barnes, Allan
    Nebro, Wesenyalsh
    Moolchan, Eric T.
    Huestis, Marilyn A.
    [J]. THERAPEUTIC DRUG MONITORING, 2006, 28 (04) : 545 - 551
  • [10] Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans
    Hart, CL
    Ward, AS
    Haney, M
    Comer, SD
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 2002, 164 (04) : 407 - 415
12345